. Author manuscript; available in PMC: 2009 Jan 26.

Published in final edited form as: J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):592–596. doi: 10.1097/QAI.0b013e318163bd87

TABLE 1.

Baseline Demographic Characteristics, CD4 Cell Count, and Blood HIV Load of Excluded Subjects and Studied Participants

Variable		HIV⁺/HSV-2⁻, Excluded n = 53	HIV⁺/HSV-2⁻, Cohort n = 119	HIV⁺/ HSV-2 Nonseroconveters n = 109	HIV⁺/HSV-2 Seroconverters n = 10
Age, median (range), y		36 (23 to 54)	35 (21 to 56)	34 (21 to 56)	36 (31 to 45)
Race, no. (%) subjects
	White	34 (83)^*	91 (76)	83 (76)	8 (80)
	Native American	0 (0)	15 (13)	14 (13)	1 (10)
	Black	2 (5)	9 (7)	9 (8)	0 (0)
	Asian	3 (7)	3 (3)	2 (2)	1 (10)
	Unknown	2 (5)	1 (1)	1 (1)	0 (0)
Ethnicity, no. (%) subjects
	Not Hispanic	16 (39)	44 (37)	39 (36)	5 (50)
	Hispanic	8 (20)	24 (20)	22 (20)	2 (20)
	Unknown	17 (41)	51 (43)	48 (44)	3 (30)
HIV stage, no. (%) subjects
	Acute	14 (34)	30 (25)	28 (26)	2 (20)
	Early	27 (66)	89 (75)	81 (74)	8 (80)
CD4 T-cell count, median (range), cells/mm³		431 (123 to 932)^†	520 (107 to 1380)	510 (107 to 1380)	545 (314 to 1193)
HIV load, median (range), log₁₀ copies/mL		5.20 (2.88 to 7.28)	5.04 (1.70 to 7.19)	5.04 (1.70 to 7.19)	4.30 (2.89 to 6.86)

P ≤ 0.015 in comparison to the HIV-1⁺/HSV-2⁻ cohort studied using the Fisher exact test.

^†

P ≤ 0.018 in comparison to the HIV-1⁺/HSV-2⁻ cohort studied using the Wilcoxon 2-sample test.